Trial Profile
Zinc monocysteine in elderly patients with mild to moderate Alzheimer's disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2011
Price :
$35
*
At a glance
- Drugs Zinc monocysteine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 18 Aug 2011 New trial record